Project Grant HT94252411007
Award Date
9/15/24
Completion Date
9/14/28
Dollars Obligated
$366K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
This Project Grant award, valued at $399,729.00, was provided by the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a research project focused on the clinical effectiveness of nonopioid pain management approaches to improve outcomes among active-duty service members. The award was granted to the University of Illinois, which will conduct this research over a 2-year period from November 1,...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The federal Project Grant award, valued at $1,122,000.00 and awarded on July 15, 2023 by the Defense Health Agency, supports the University of North Carolina at Chapel Hill's research project titled "ENGAGING MOTOR CORTEX ANTINOCICEPTIVE CIRCUITS TO TREAT CHRONIC PAIN UNPLEASANTNESS". The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to study how engaging the motor cortex can be used to treat chronic pain. As a sub-award under this...
This Project Grant award from the Defense Health Agency provides $1,606,737 to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2026. The award supports the development of non-opiode GPCR signaling-biased agents for pain management by advancing a series of compounds represented by SBI-810 and SBI-553 toward an Investigational New Drug application. Under a subaward of $156,000, the University of...
This federal Project Grant award of $737,500 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research into a novel treatment for spinal cord injury-related neuropathic pain by targeting fibroblast-derived PI16. The award recipient is Florida International University (FIU), a public research university in Miami, Florida that is designated as a Hispanic-Serving Institution and a leading minority-serving institution....
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,352,128.00 to the University of Miami for the development of human iPSC-derived chromaffin cell transplants for the treatment of chronic pain. The three-year award, which began on July 15, 2024 and runs through July 14, 2027, supports the university's research to investigate innovative therapeutic approaches for addressing chronic pain conditions...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
Duke University was awarded a $1,608,140 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to develop non-opioid G protein-coupled receptor signaling-biased agents for pain management. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The New York University will receive $936,199 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this three-year award beginning September 2022, New York University researchers will investigate receptors in endosomes that mediate chronic pain associated with trauma,...